StonvexLoading…
StonvexStonvexStonvexCore line items from BMNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.58M | $12.78M | $13.59M | $13.00M |
Operating Income | $4.49M | $1.81M | $147.36K | $-7.97M |
Net Income | $5.80M | $-1.31M | $-3.98M | $-19.82M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $129.69M | $154.85M | $125.60M | $86.32M |
Total Liabilities | $117.07M | $148.03M | $117.47M | $74.19M |
Cash & Equivalents | $12.70M | $5.67M | $3.72M | $6.01M |
Free Cash Flow OCF − CapEx | Not available | Not available | $1.70M | $5.43M |
Shares Outstanding | Not available | Not available | Not available | Not available |